Article thumbnail

Atrazine and Breast Cancer: A Framework Assessment of the Toxicological and Epidemiological Evidence

By James W. Simpkins, James A. Swenberg, Noel Weiss, David Brusick, J. Charles Eldridge, James T. Stevens, Robert J. Handa, Russell C. Hovey, Tony M. Plant, Timothy P. Pastoor and Charles B. Breckenridge

Abstract

The causal relationship between atrazine exposure and the occurrence of breast cancer in women was evaluated using the framework developed by Adami et al. (2011) wherein biological plausibility and epidemiological evidence were combined to conclude that a causal relationship between atrazine exposure and breast cancer is “unlikely”. Carcinogenicity studies in female Sprague-Dawley (SD) but not Fischer-344 rats indicate that high doses of atrazine caused a decreased latency and an increased incidence of combined adenocarcinoma and fibroadenoma mammary tumors. There were no effects of atrazine on any other tumor type in male or female SD or Fischer-344 rats or in three strains of mice. Seven key events that precede tumor expression in female SD rats were identified. Atrazine induces mammary tumors in aging female SD rats by suppressing the luteinizing hormone surge, thereby supporting a state of persistent estrus and prolonged exposure to endogenous estrogen and prolactin. This endocrine mode of action has low biological plausibility for women because women who undergo reproductive senescence have low rather than elevated levels of estrogen and prolactin. Four alternative modes of action (genotoxicity, estrogenicity, upregulation of aromatase gene expression or delayed mammary gland development) were considered and none could account for the tumor response in SD rats. Epidemiological studies provide no support for a causal relationship between atrazine exposure and breast cancer. This conclusion is consistent with International Agency for Research on Cancer’s classification of atrazine as “unclassifiable as to carcinogenicity” and the United States Environmental Protection Agency's classification of atrazine as “not likely to be carcinogenic.

Topics: Endocrine Toxicology
Publisher: Oxford University Press
OAI identifier: oai:pubmedcentral.nih.gov:3179673
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2000). 2-chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: A novel mechanism for estrogenicity.
  2. (2008). 2-fluoro-2-deoxy-D glucose positron emission tomography demonstration of estrogen negative and positive feedback on luteinizing hormone secretion in women.
  3. (1975). A bioassay for screening host-mediated proximal mutagens in agriculture (Abstract).
  4. (2004). A comparison of human H295R and rat R2C cell lines as in vitro screening tools for effects on aromatase.
  5. (2003). A framework for human relevance analysis of information on carcinogenic modes of action.
  6. (2006). A framework for using epidemiology data for risk assessment.
  7. (1992). A method for comparing, combining and interpreting short-term genotoxicity test data.
  8. (1992). A method for comparing, combining short-term genotoxicity test data: the basic system.
  9. (2004). A nested case-control study of prostate cancer and atrazine exposure.
  10. (2004). A novel nonradioactive method for measuring aromatase activity using a human ovarian granulosa-like tumor cell line and an estrone ELISA.
  11. (2007). A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women’s Midlife Health Project.
  12. (1980). A review of the coordinated research effort on the comparison of test systems for the detection of mutagenic effects.
  13. (2011). A review of the epidemiologic studies of triazine herbicides and cancer.
  14. (1999). A risk characterization for atrazine: oncogenicity profile.
  15. A Summary of General Assessment Factors for Evaluating the Quality of Scientific and
  16. (2005). Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth.
  17. (1984). Age-related alternatives in catecholamine activity with microdissected brain regions of ovariectomized Fischer 344 rats.
  18. (1976). Aging in the hypothalamic-hypophyseal ovarian axis in the rat.
  19. (1997). Aging of the female reproductive system: a window into brain aging. Recent Prog.
  20. (1997). Alterations in steroidogenesis in alligators (Alligator mississippiensis) exposed naturally and experimentally to environmental contaminants.
  21. (1994). An assessment of the genetic toxicity of atrazine: relevance to human health and environmental effects.
  22. (1999). Analysis of DNA strand breaks, oxidized bases, and glutathione S-transferase P1 in human cells. Cancer Epidemiol. Biomarkers Prev.
  23. Anatomy of the kisspeptin neural network in mammals.
  24. (2009). and Agricultural Organization of the United Nations (FAO) and the World Health Organization (WHO).
  25. (1995). Androgen biosynthesis and secretion in developing Xenopus laevis.
  26. (2008). APVMA (Australian Pesticides and Veterinary Medicines Authority).
  27. (2004). Atrazine alters steroidogenesis in male Wistar rats.
  28. (2007). Atrazine and reproductive function: mode and mechanism of action studies. Birth Defects Res.
  29. (1989). Atrazine and the genotoxicity of its metabolites.
  30. (2000). Atrazine disrupts the hypothalamic control of pituitary-ovarian function.
  31. (2009). Atrazine inhibits pulsatile luteinizing hormone release without altering pituitary sensitivity to a gonadotropin-releasing hormone receptor agonist in female Wistar rats.
  32. (2008). Atrazine interaction with estrogen expression systems.
  33. (2011). Atrazine Technical Report. The Reconsideration of the Active Constituent Registration of Products Containing Atrazine and Approval of Their Associated Labels. Available at: http://www.apvma.gov.au. Accessed
  34. (1995). Atrazine treatment potentiates excretion of mutagenic urine in 2,6-dinitrotoluene treated Fischer 344 rats.
  35. (2008). Atrazine-induced changes in aromatase activity in estrogen sensitive target tissues.
  36. (1969). Bioassay of pesticides and industrial chemicals for tumorigenicity in mice: a preliminary note.
  37. (1996). Biochemical and genetic interactions of two commercial pesticides with the monooxygenase system and chlorophyllin.
  38. (1979). Blockade of steroid induced LH release by selective depletion of anterior hypothalamic norepinephrine activity.
  39. (2004). Breast cancer incidence and its possible spatial association with pesticide application in two counties of England.
  40. (2002). Cancer incidence among triazine herbicide manufacturing workers.
  41. (2001). Cancer risk related to mammary gland structure and development.
  42. (2009). Characterization of the hypothalamic-pituitary-adrenal axis response to atrazine and metabolites in the female rat.
  43. (1986). Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle.
  44. (2009). Chlorotriazine herbicides and metabolites activate an ACTH-dependent release of corticosterone in male Wistar rats.
  45. (1995). Chromosomal damage induced by herbicide contamination at concentrations observed in public water supplies.
  46. (1979). Chronological changes in sex steroid, gonadotropin and prolactin secretion in aging female rats displaying different reproductive states.
  47. (1978). Clinical Aspects of aging of the female reproductive system.
  48. (2001). Comet assay and early apoptosis.
  49. (2001). Comparing the clastogenic potential of atrazine with caffeine using Chinese hamster ovary (CHO) cells.
  50. (2001). Comparison of the absorption, metabolism and elimination of atrazine administered orally to man or orally or intravenously to rhesus monkey.
  51. (2006). Control of follicular development, corpus luteum function, the maternal recognition of pregnancy, and the neuroendocrine regulation of the menstrual cycle in higher primates.
  52. (1980). Control of the rhesus monkey menstrual cycle: permissive role of hypothalamic gonadotropin-releasing hormone.
  53. (1986). Cyclic ovarian function in a male macaque: additional evidence for a lack of sexual differentiation in the physiological mechanisms that regulate the cyclic release of gonadotropins in primates.
  54. (1992). Cytogenetic effects of alachlor and/or atrazine in vivo and in vitro.
  55. (2000). Cytogenetic studies of three triazine herbicides I. In vitro studies.
  56. (2000). Cytogenetic studies of three triazine herbicides. II. In vivo micronucleus studies in mouse bone marrow.
  57. (1972). Cytogenetic studies with atrazine on plants.
  58. (1982). Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting pituitary tumors.
  59. (1994). Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women.
  60. (2002). Detection of estrogenic activity in sediment-associated compounds using in vitro reporter gene assays.
  61. (2009). Development of a competitive binding assay system with recombinant estrogen receptors from multiple species.
  62. (1980). Differential patterns of gonadotropin responses to ovarian steroids and to LH-releasing hormone between constant-estrous and pseudopregnant states in aging rats.
  63. (1988). DNA damage in stomach, kidney, liver and lung of rats treated with atrazine.
  64. (2009). Does atrazine affect larval development and sexual differentiation of South African clawed frogs?
  65. (2009). Does atrazine influence larval development and sexual differentiation in Xenopus laevis?
  66. (2004). Dose-dependent transitions in mechanisms of toxicity: case studies.
  67. (2004). Dose-dependent transitions in mechanisms of toxicity.
  68. (2008). Early life events and conditions and breast cancer risk: From epidemiology to etiology.
  69. (2009). Effects of atrazine and its withdrawal on gonadotropin-releasing hormone neuroendocrine function in the adult female Wistar rat.
  70. (2005). Effects of atrazine on CYP19 gene expression and aromatase activity in testes and on plasma sex steroid concentrations of male African clawed frogs (Xenopus laevis).
  71. (2010). Effects of Atrazine on Neuroendocrine Function in Male and Female Rats.
  72. (2001). Effects of chloro-s-triazine herbicides and metabolites on ATRAZINE,
  73. (2003). Effects of environmental estrogenic compounds on growth of a transplanted estrogen responsive pituitary tumor cell line in rats.
  74. (1974). Effects of hypothalamic deafferentation on the pulsatile rhythm in plasma concentrations of luteinizing hormone in ovariectomized rats.
  75. (2006). Effects of in ovo exposure to imazalil and atrazine on sexual differentiation in chick gonads.
  76. (2004). Effects of organochlorine compounds on cytochrome P450 aromatase activity in an immortal sea turtle cell line.
  77. (2011). Effects on antioxidant status of liver following atrazine exposure and its attenuation by vitamin E.
  78. (1997). Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins.
  79. (2002). Establishing a framework for the functional mammary gland: from endocrinology to morphology.
  80. (1999). Estrous cycle patterns of Sprague-Dawley rats during acute and chronic atrazine administration.
  81. (1996). Failure of chloro-s-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro.
  82. (1995). First Geoffrey Harris Memorial Lecture. Some recent developments in brain-pituitary-ovarian physiology.
  83. (1995). Flow cytogenetic analysis of whole cell clastogenicity of herbicides found in groundwater.
  84. (2009). for Ecotoxicology and Toxicology of Chemicals.
  85. (1994). Genotoxic effects of the herbicides alachlor, atrazine, pendimethaline, and simazine in mammalian cells.
  86. (1998). Genotoxicity of radiofrequency radiation, DNA/Genetox Expert Panel.
  87. (1997). Genotoxicity of select herbicides in Rana catesbeiana tadpoles using the alkaline single-cell gel DNA electrophoresis (Comet) assay.
  88. (1986). Gonadal regulation of hypothalamic gonadotropinreleasing hormone release in primates.
  89. (2005). Guidelines for Carcinogenic Risk Assessment; Risk Assessment Forum EPA/630/P-03/001B, United States Environmental Protection Agency,
  90. (2001). HED Standard Operating Procedure: Executive Summaries for Toxicology Data Evaluation Records (DERs) SOP 2001.02. United States Environmental Protection Agency,
  91. (1995). Herbicide-induced DNA damage in human lymphocytes evaluated by the single-cell gel electrophoresis (SCGE) assay.
  92. (2002). Hermaphroditic, demasculinized frogs after exposure to the herbicide atrazine at low ecologically relevant doses.
  93. (1979). Historical Foundations. In The Laboratory Rat. Volume I. Biology and Disease
  94. (1981). Hormonal actions on the sexual differentiation of the genitalia and the gonadotropin-regulating systems.
  95. (2009). Hormonal changes and biomarkers in late reproductive age, menopausal transition and menopause.
  96. (1999). HPLC-acelerator MS measurement of atrazine metabolites in human urine after dermal exposure.
  97. (2010). Human metabolism of atrazine.
  98. (1978). Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone.
  99. (1994). Hypothesis for mammary tumorigenesis in Sprague-Dawley rats exposed to certain triazine herbicides.
  100. (1977). In Vitro and In Vivo Microbiological Assays of Six Ciba-Geigy Chemicals: Final Report Rep. N : SRI Project LSC-5686.
  101. (1993). In vitro percutaneous adsorption and metabolism in man of 2-chloro-4-ethylamino-6-isopropylamine-s-triazine (atrazine).
  102. (1997). In vivo genotoxicity of selected herbicides in the mouse bone-marrow micronucleus test.
  103. (1992). Influence of age and parity on the development of the human breast.
  104. (2003). Interim Reregistration Eligibility Decision for Atrazine.
  105. (1986). Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.
  106. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis.
  107. (1998). Is GnRH reduced at the midcycle surge in the human. Evidence from a GnRH-deficient model.
  108. (2009). Kisspeptin signaling in the brain.
  109. (1998). Lack of genotoxicity of the herbicide atrazine in cultured human lymphocytes.
  110. (1990). Long-term carcinogenicity bioassay of the herbicide atrazine in F 344 rats.
  111. (2007). Mammary gland development as a sensitive end point after acute prenatal exposure to an atrazine metabolite mixture in female Long-Evans rats.
  112. (2009). Menopause and the human hypothalamus: evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback.
  113. (2008). Mode of action of atrazine for mammary tumor formation in the female Sprague-Dawley rat. In The Triazine Herbicides: 50 Years Revolutionizing Agriculture
  114. (1999). Monitoring of estrogen mimics by a recombinant yeast assay: synergy between natural and synthetic compounds.
  115. (1999). Monographs on the Evaluation of Carcinogenic Risks to Humans. Evaluation and re-evaluation of some agents which target specific organs in rodent bioassays,
  116. (2003). Mortality among triazine herbicide manufacturing workers.
  117. (1982). Mutagenic efficiency of atrazine with and without metabolic activation.
  118. (2006). Nature of the binding interaction for 50 structurally diverse chemicals with rat estrogen receptors.
  119. (2009). Neuroendocrine control of the menstrual cycle.
  120. (2006). Neuroendocrine control of the ovarian cycle of the rat.
  121. (1999). Neuroendocrine modulation of the "menopause": insights into the aging brain.
  122. (2010). Neurokinin B and dynorphin A in kisspeptin neurons of the arcuate nucleus participate in generation of periodic oscillation of neural activity driving pulsatile gonadotropin-releasing hormone secretion in the goat.
  123. (1985). Noradrenergic methods in neuroendocrinology.
  124. (1997). Noradrenergic regulation of cyclic GnRH secretion.
  125. (1982). Normal LHRH neuronal function and hyperprolactinemia in old pseudopregnant Fischer 344 rats.
  126. (2002). Office of Pesticide Programs, Health Effects Division. The Grouping of a Series of Triazine Pesticides Based on a Common Mechanism of Toxicity. United States Environmental Protection Agency,
  127. (1974). On the control of gonadotropin secretion in the rhesus monkey. Recent Prog.
  128. (2005). Perimenopausal reproductive endocrinology.
  129. (1993). Pesticide Reregistration Rejection Rate Analysis—Toxicology 738R93004.UnitedStatesEnvironmentalProtectionAgency,Washington,DC.
  130. (2005). Pesticide use and breast cancer risk among farmers’ wives in the Agricultural Health Study.
  131. (2010). Pesticides and Veterinary Medicines Authority).
  132. (2003). Pharmacokinetic modeling of disposition and timecourse studies with [ 14C] atrazine.
  133. (2011). Pharmacokinetics of [ 14C]-atrazine in rhesus monkeys, single-dose intravenous and oral administration.
  134. (1994). Photochemical decomposition of organic compounds in water after UV-irradiation: investigation of positive mutagenic effects.
  135. (2005). Plasma concentrations of estradiol and testosterone, gonadal aromatase activity and ultrastructure of the testis in Xenopus laevis exposed to estradiol or atrazine.
  136. (2004). Plasma sex steroid concentrations and gonadal aromatase activities in African clawed frogs (Xenopus laevis) from South Africa.
  137. (1977). Positive feedback of oestrogen on LH secretion in women in neuroleptic drugs.
  138. (1993). Preovulatory gonadotropin-releasing hormone surge in ovarian-intact rhesus macaques.
  139. (1995). Principles for Evaluating Epidemiologic Data in Regulatory Risk Assessment, ISBN 0-9654148-0-9, and "Recommendations for Implementing the ’London Principles’ for Risk Assessment Guidance, Federal Focus
  140. (1982). Progress Report (Jan.–Oct.
  141. (2008). Protective effects of vitamin E against atrazine-induced genotoxicity in rats.
  142. (2010). Quantitative assessment of mammary gland development in female Long Evans rats following in utero exposure to atrazine.
  143. (1978). Recent studies on neuroendocrine control of reproductive senescence in rats.
  144. (2002). Regional assessment of atrazine exposure and incidence of breast and ovarian cancers in Kentucky.
  145. (2006). Regression analysis of pesticide use and breast cancer incidence in California Latinas.
  146. (2005). Residential proximity to agricultural pesticide use and incidence of breast cancer
  147. (2004). Residential proximity to agricultural pesticide use and incidence of breast cancer in the California Teachers Study cohort.
  148. (1998). Results of a two-year oncogenicity study in fischer 344 rats with atrazine. Chapter 30. In Triazine Herbicides: Risk Assessment
  149. (2007). Risk of breast cancer for women living in rural areas from adult exposure to atrazine from well water in Wisconsin.
  150. (2000). Role of prolactin in chloro-s-triazine rat mammary tumorigenesis.
  151. (1998). Role of strain-specific reproductivepatternsintheappearanceofmammarytumorsinatrazine-treated rats. In Triazine Herbicides: Risk Assessment
  152. (1978). SCE Test In Vivo: Chromosome Aberrations in Bone Marrow Cells.
  153. (1975). Serum prolactin and LH in early phases of delayed and direct pseudopregnancy in the rat.
  154. (1973). Sexual differentiation of pituitary function: apparent difference between primates and rodents.
  155. (1984). Sister chromatid exchanges induced in human lymphocyte chromosomes by trifluralin, atrazine and simazine.
  156. Special Review and Reregistration Division.
  157. (2005). Statistical inferences about the mechamism of action in carcinogenicity.
  158. (1975). Surgical disconnection of the medial basal hypothalamus and pituitary function in the rhesus monkey.
  159. (1996). Symposium overview: Endocrine Modulation of Reproduction.
  160. (1998). The clastogenic potential of triazine herbicide combinations found in potable water supplies.
  161. (2006). The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention.
  162. (2011). The differential effect of atrazine on luteinizing hormone release in adrenalectomized adult female Wistar rats.
  163. (1981). The effect of atrazine on sister-chromatid exchange in maize.
  164. (2000). The effects of atrazine on female Wistar rats: An evaluation of the protocol for assessing pubertal development and thyroid function.
  165. (2002). The effects of atrazine on the sexual maturation of female rats.
  166. (2011). The effects of prenatal exposure to atrazine on pubertal and postnatal reproductive indices in the female rat.
  167. (1999). The functional and structural observations of the neonatal reproductive system of alligators exposed in ovo to atrazine, 2,4-d, or estradiol.
  168. (1994). The gonadotropinreleasing hormone (GnRH), neuronal systems: Immunocytochemistry and in situ hybridization.
  169. (1999). The mammary tumor response in triazine-treated female rats: a thresholdmediated interaction with strain and species-specific reproductive senescence.
  170. (1994). The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency.
  171. (1980). The neuroendocrine control of the menstrual cycle. Recent Prog.
  172. (1978). The site of the positive feedback action of estradiol in the rat.
  173. (1981). The sites of action of ovarian steroids in the regulation of LH secretion.
  174. (2007). The strengthening of the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies.
  175. (2000). Tissuespecific synthesis and oxidative metabolism of estrogens.
  176. (2011). Toxicology and epidemiology: improving the science with a framework for combining toxicological and epidemiological evidence to establish causal inference.
  177. (2006). Triazine Cumulative Risk Assessment. HED Human Health Risk Assessment in Support of the Reregistration Eligibility Decisions for Atrazine, Simazine and Propazine.
  178. Triazine herbicide exposure and breast cancer incidence: An ecologic study of Kentucky counties.
  179. (2011). Understanding the effects of atrazine on steroidogenesis in rat granulosa and H295R adrenal cortical carcinoma cells.